WHWK Whitehawk Therapeutics, Inc. - Common Stock
NASDAQ · Biotechnology · 在 SEC EDGAR 上查看 ↗ 收盘 十月 2, 2026 10-K/10-Q 八月 6, 2026
$3.70
· % 处于52周区间
· 高于低点
· 至高点
$1.8752周低点
$5.5052周高点
市值 (MRQ)
$211M
P/E (TTM)
-1.9
EPS (TTM)
$-1.92
收入 (TTM)
$0
WHWK 股票快照 价格、市值、P/E、EPS、ROE、负债/权益、52周范围
价格
$3.70
市值 (MRQ)
$211M
P/E (TTM)
-1.9
EPS (TTM)
$-1.92
收入 (TTM)
$0
ROE (TTM)
-45.0%
52周区间
$2–$5
WHWK 股价图表 包含技术指标的日 OHLCV — 平移、缩放和自定义您的视图
区间
条形图
柱状图粒度会根据所选周期进行调整 — 将鼠标悬停在图表上可查看柱状图的开盘价/最高价/最低价/收盘价。
股票拆分
| 除息日 | 拆股 | 类型 |
|---|---|---|
| 2021年8月27日 | 1-for-15 | 反向 |
10年表现 收入、净利润、利润率和每股收益趋势
收入$7M2018-12-31 → 2025-12-31
EPS$-0.332021-12-31 → 2025-12-31
自由现金流$-98M2018-12-31 → 2025-12-31
净利率-288.3%2018-12-31 → 2025-12-31
估值与比率
估值 P/E、P/S、P/B、EV/EBITDA 比率 — 该股票是昂贵还是便宜？
| 指标 | 5年趋势 | WHWK | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| P/E (TTM) | -1.95年均值 ≈-3.2 | ≈-3.2 | · | · | |
| P/S | 24.45年均值 ≈15.5 | ≈15.5 | 16.1 | 公允价值 | |
| 市净率 (MRQ) | 1.25年均值 ≈1.7 | ≈1.7 | 2.5 | 低估 | |
| 股价/自由现金流 (TTM) | -3.05年均值 ≈-6.4 | ≈-6.4 | · | · | |
| 市现率 (TTM) | -3.05年均值 ≈-6.4 | ≈-6.4 | · | · | |
| Price / Tangible Book (市净率（有形资产）) | 1.35年均值 ≈1.7 | ≈1.7 | · | · |
同行中位数按每项指标的标准化基础计算，可能与本股票显示的TTM/MRQ基础不完全匹配。
盈利能力 毛利率、营业利润率和净利率；股本回报率 (ROE)、资产回报率 (ROA)、投入资本回报率 (ROIC)
| 指标 | 5年趋势 | WHWK | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| Operating Margin (营业利润率) | -1601.1%5年均值 ≈-2499.6% | ≈-2499.6% | -1113.3% | 弱 | |
| EBITDA Margin (息税折旧摊销前利润率) | -1600.0%5年均值 ≈-2497.0% | ≈-2497.0% | -1113.3% | 弱 | |
| Pretax Margin (税前利润率) | -288.3%5年均值 ≈-2206.1% | ≈-2206.1% | -688.6% | 顶尖 | |
| Net Profit Margin (净利润率) | -288.3%5年均值 ≈-2206.1% | ≈-2206.1% | -1287.2% | 顶尖 | |
| ROA (TTM) | -42.6%5年均值 ≈-56.6% | ≈-56.6% | -27.9% | 顶尖 | |
| ROE (TTM) | -45.0%5年均值 ≈-58.2% | ≈-58.2% | -27.2% | 顶尖 | |
| ROIC | -83.9%5年均值 ≈-80.4% | ≈-80.4% | -67.7% | 低于平均水平 |
财务健康 债务、流动性、偿付能力 — 资产负债表强度
| 指标 | 5年趋势 | WHWK | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| 流动比率 (MRQ) | 17.45年均值 ≈7.6 | ≈7.6 | 7.9 | 流动性强 | |
| Quick Ratio (速动比率) | 10.05年均值 ≈7.3 | ≈7.3 | 6.5 | 流动性强 |
成长 营收、每股收益 (EPS) 和净利润增长：同比、3年复合年增长率 (CAGR)、5年复合年增长率 (CAGR)
| 指标 | 5年趋势 | WHWK | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| Revenue YoY (营收同比增长) | -72.5%5年均值 ≈0.59% | ≈0.59% | · | · | |
| Revenue CAGR 3Y (营收3年复合年增长率) | -22.3%5年均值 ≈7.0% | ≈7.0% | · | · | |
| Revenue CAGR 5Y (营收5年复合年增长率) | -12.6% | · | · | · |
资本效率 资产周转率、库存周转率、应收账款周转率
| 指标 | 5年趋势 | WHWK | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| Asset Turnover (资产周转率) | 0.15年均值 ≈0.1 | ≈0.1 | 0.1 | 持平 | |
| Inventory Turnover (库存周转率) | 0.35年均值 ≈0.7 | ≈0.7 | · | · | |
| Receivables Turnover (应收账款周转率) | 2.45年均值 ≈7.5 | ≈7.5 | 2.6 | 弱 | |
| Revenue / Employee (年营业收入 ÷ 员工人数（报告的 headcount，yfinance）。衍生数据 — 非存储的 SEC-XBRL 概念。) | ≈$223.3K | · | · | · |
价值 · ≈ 5年均值 · 行业中值 · 相对于中值的评判
收益历史 每股收益实际值 vs 预估值，惊喜%，达标率，下次财报日期
平均惊喜
-130.5%
下次报告
十一月 04, 2026
| 期间 | 报告 | EPS Actual | EPS 预期 | 惊喜 |
|---|---|---|---|---|
| 2026年6月30日 | 八月 5, 2026 | $-0.20 | $-0.30 | 33.7% |
| 2026年3月31日 | $-0.32 | $-0.36 | 12.1% | |
| 2025年12月31日 | $-0.34 | $-0.16 | -116.4% | |
| 2025年9月30日 | $-0.26 | $0.07 | -482.4% | |
| 2025年6月30日 | $-0.76 | $0.50 | -251.0% | |
| 2025年3月31日 | $-0.37 | $-0.47 | 21.1% |
完整基本面 所有年度指标 — 损益表、资产负债表、现金流量表
损益表
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $7M | $26M | $24M | $15M | $14M | $14M | $0 | $20M | |
| Cost of Revenue | $760.0K | $3M | $3M | $1M | $0 | · | · | · | |
| R&D Expense | $91M | $51M | $49M | $33M | $20M | $15M | $13M | $18M | |
| SG&A Expense | $30M | $37M | $45M | $40M | $19M | $2M | $10M | $13M | |
| Operating Expenses | $122M | $93M | $96M | $78M | $112M | $17M | $24M | $31M | |
| Operating Income | $-114M | $-67M | $-72M | $-63M | $-111M | $-3M | $-24M | $-11M | |
| Interest Expense | · | · | $231.0K | $230.0K | $665.0K | $815.0K | · | · | |
| Interest Income | $6M | $4M | $6M | $2M | $13.0K | $41.0K | · | · | |
| Other Non-op | $94M | $4M | $6M | $2M | $1M | $-927.0K | $1M | $784.6K | |
| Pretax Income | $-21M | $-64M | $-66M | $-61M | $-110M | $-3M | · | · | |
| Income Tax | $0 | $0 | $0 | $0 | $2.0K | $2.0K | · | · | |
| Net Income | $-21M | $-64M | $-66M | $-61M | $-110M | $-3M | $-23M | $-10M | |
| EPS (Basic) | $-0.33 | $-2.36 | $-2.44 | $-2.69 | $-12.41 | · | · | · | |
| EPS (Diluted) | $-0.33 | $-2.36 | $-2.44 | $-2.69 | $-12.41 | · | · | · | |
| Shares (Basic) | 61,886,765 | 27,029,942 | 26,917,967 | 22,511,237 | 8,923,369 | · | · | · | |
| Shares (Diluted) | 61,886,765 | 27,029,942 | 26,917,967 | 22,511,237 | 8,923,369 | · | · | · | |
| EBITDA | $-114M | $-67M | $-72M | $-63M | $-111M | $-6M | $-24M | $-11M |
资产负债表
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $38M | $29M | $63M | $39M | $149M | $4M | $39M | $63M | |
| Short-term Investments | $108M | $19M | $46M | $134M | $0 | · | · | · | |
| Receivables | $0 | $6M | $5M | $2M | $0 | $14M | · | · | |
| Inventory | $0 | $5M | $6M | $2M | $0 | · | · | · | |
| Prepaid Expense | $3M | $3M | $4M | $4M | $2M | $81.0K | $311.2K | $754.4K | |
| Other Current Assets | · | · | · | · | · | $2M | $734.8K | $615.7K | |
| Current Assets | $149M | $61M | $125M | $180M | $151M | $19M | $40M | $64M | |
| PP&E (Net) | $3.0K | $7M | $5M | $508.0K | $57.0K | $21.0K | $164.2K | $98.4K | |
| PP&E (Gross) | $377.0K | $7M | $5M | $609.0K | $87.0K | $512.1K | $493.0K | $409.6K | |
| Accum. Depreciation | $374.0K | $463.0K | $270.0K | $101.0K | $30.0K | $390.3K | $328.9K | $311.1K | |
| Intangibles | · | · | · | $0 | $4M | · | · | · | |
| Other Non-current Assets | $2M | $1M | $2M | $2M | $2M | · | · | · | |
| Total Assets | $151M | $70M | $132M | $184M | $158M | $19M | $40M | $64M | |
| Accounts Payable | $917.0K | $2M | $6M | $4M | $6M | $2M | $439.8K | $595.7K | |
| Accrued Liabilities | $14M | $15M | $14M | $15M | $9M | $4M | · | · | |
| Current Liabilities | $15M | $17M | $26M | $19M | $15M | $30M | $3M | $5M | |
| Capital Leases | $0 | $565.0K | $833.0K | $1M | $474.0K | · | $67.4K | · | |
| Other Non-current Liabilities | $0 | $202.0K | $0 | · | $0 | $97.0K | · | · | |
| Total Liabilities | $15M | $18M | $27M | $26M | $22M | $31M | $3M | $5M | |
| Common Stock | $4.0K | $2.0K | $2.0K | $2.0K | $2.0K | $1.0K | $4.1K | $4.1K | |
| Retained Earnings | $-353M | $-333M | $-269M | $-203M | $-143M | $-33M | $-142M | $-119M | |
| AOCI | $120.0K | $16.0K | $27.0K | $-115.0K | $0 | · | · | · | |
| Stockholders' Equity | $136M | $52M | $105M | $158M | $136M | $-12M | $-9M | $59M | |
| Liabilities + Equity | $151M | $70M | $132M | $184M | $158M | $19M | $40M | $64M | |
| Shares Outstanding | 47,145,719 | 24,681,000 | 24,554,000 | 24,435,000 | 20,895,000 | 2,542,358 | 40,588,004 | 40,588,004 |
现金流
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| D&A | $79.0K | $193.0K | $169.0K | $159.0K | $105.0K | $9.0K | · | · | |
| Stock-based Comp | $10M | $11M | $12M | $10M | $2M | $139.0K | $1M | $3M | |
| Deferred Tax | · | · | · | · | $0 | $0 | $0 | $0 | |
| Amort. of Intangibles | · | · | $0 | $87.0K | $95.0K | $0 | · | · | |
| Restructuring | $0 | $3M | $0 | · | · | · | · | · | |
| Other Non-cash | $-87M | $-7M | $-6M | $1M | $85M | · | · | · | |
| Operating Cash Flow | $-97M | $-60M | $-60M | $-50M | $-22M | $-13M | $-24M | $-6M | |
| CapEx | $552.0K | $2M | $4M | $444.0K | $46.0K | $19.0K | $237.0K | $37.9K | |
| Investing Cash Flow | $12M | $25M | $83M | $-133M | $25M | $-19.0K | $-237.0K | $-37.9K | |
| Stock Issued | · | · | · | $0 | $155M | $10M | · | $52M | |
| Net Stock Activity | · | · | · | $0 | $155M | $10M | · | $52M | |
| Dividends Paid | · | · | · | $0 | $4M | · | · | · | |
| Financing Cash Flow | $94M | $130.0K | $326.0K | $73M | $142M | $1M | · | $48M | |
| Net Change in Cash | $9M | $-34M | $24M | $-110M | $145M | $-12M | $-24M | $42M | |
| Free Cash Flow | $-98M | $-61M | $-64M | $-50M | $-22M | $-5M | $-24M | $-6M | |
| Levered FCF | · | · | $-64M | $-50M | $-23M | · | · | · |
盈利能力
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -1601.1% | -259.6% | -295.4% | -411.9% | -9930.1% | -42.4% | · | -55.5% | |
| Net Margin | -288.3% | -245.1% | -270.0% | -397.7% | -9829.5% | -28.8% | · | -51.6% | |
| Pretax Margin | -288.3% | -245.1% | -270.0% | -397.7% | -9829.3% | · | · | · | |
| EBITDA Margin | -1600.0% | -258.9% | -294.7% | -410.9% | -9920.7% | -42.4% | · | -55.5% | |
| ROA | -18.6% | -62.8% | -41.5% | -35.4% | -124.6% | -10.2% | -44.7% | -24.4% | |
| ROE | -13.4% | -105.0% | -58.9% | -37.0% | -76.6% | -38.2% | -59.5% | -16.6% | |
| ROIC | -83.9% | -128.6% | -68.4% | -39.6% | -81.5% | · | · | · |
流动性与偿付能力
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 10.3 | 3.6 | 4.7 | 9.6 | 9.9 | 24.0 | 11.9 | 11.7 | |
| Quick Ratio | 10.0 | 3.1 | 4.3 | 9.3 | 9.8 | 22.8 | 11.6 | 11.5 | |
| Interest Coverage | · | · | -311.4 | -272.5 | -167.2 | · | · | · |
效率
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.3 | 0.2 | 0.1 | 0.0 | 0.4 | · | 0.5 | |
| Inventory Turnover | 0.3 | 0.5 | 0.7 | 1.4 | · | · | · | · | |
| Receivables Turnover | 2.4 | 4.6 | 6.6 | 16.3 | · | · | · | · |
每股
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $2.89 | $2.13 | $4.28 | $6.48 | $6.53 | $0.91 | $0.90 | $1.45 | |
| Revenue / Share | $0.12 | $0.96 | $0.90 | $0.68 | · | · | · | · | |
| Cash Flow / Share | $-1.57 | $-2.20 | $-2.22 | $-2.21 | · | · | · | · | |
| Cash / Share | $0.80 | $1.16 | $2.56 | $1.60 | $7.13 | $0.90 | $0.95 | $1.54 | |
| EPS (TTM) | $-0.33 | $-2.36 | $-2.44 | $-2.69 | $-12.41 | · | · | · |
增长率
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -72.5% | 6.7% | 60.1% | 8.7% | 0.00% | · | · | · | |
| Revenue CAGR 3Y | -22.3% | 22.9% | 20.3% | · | · | · | · | · | |
| Revenue CAGR 5Y | -12.6% | · | · | · | · | · | · | · |
估值 (TTM)
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $7M | $26M | $24M | $15M | $14M | $14M | $0 | $20M | |
| Net Income TTM | $-21M | $-64M | $-66M | $-61M | $-110M | $-3M | $-23M | $-10M | |
| Market Cap | $114M | $78M | $50M | $314M | $505M | $695M | $380M | $1.03B | |
| P/E | -7.3 | -1.3 | -0.8 | -4.8 | -1.9 | · | · | · | |
| P/S | 16.0 | 3.0 | 2.0 | 20.6 | 36.0 | 49.6 | · | 51.3 | |
| P/B | 0.8 | 1.5 | 0.5 | 2.0 | 3.7 | 16.1 | 10.4 | 17.6 | |
| P / Tangible Book | 0.8 | 1.5 | 0.5 | 2.0 | 3.8 | · | · | · | |
| P / Cash Flow | -1.2 | -1.3 | -0.8 | -6.3 | -22.5 | -129.0 | -15.9 | -178.2 | |
| P / FCF | -1.2 | -1.3 | -0.8 | -6.3 | -22.5 | -128.5 | -15.8 | -177.0 | |
| Dividend Yield | · | · | · | 0.00% | 0.87% | · | · | · | |
| Earnings Yield | -13.6% | -74.8% | -120.8% | -21.0% | -51.4% | · | · | · | |
| Payout Ratio | · | · | · | 0.00% | -4.0% | · | · | · | |
| Annual Payout | · | · | · | $0 | $4M | · | · | · |
损益表
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $7M | $7M | $7M | $6M | $5M | $6M | $6M | $6M | $6M | $5M | $4M | |
| Cost of Revenue | $0 | $0 | $0 | $0 | $0 | $760.0K | $790.0K | $804.0K | $778.0K | $652.0K | $927.0K | $697.0K | $656.0K | $529.0K | $222.0K | $593.0K | |
| R&D Expense | $13M | $17M | $19M | $14M | $49M | $9M | $14M | $10M | $13M | $14M | $13M | $12M | $13M | $11M | $9M | $9M | |
| SG&A Expense | $5M | $6M | $6M | $5M | $6M | $13M | $11M | $7M | $8M | $11M | $10M | $11M | $12M | $11M | $11M | $10M | |
| Operating Expenses | $18M | $24M | $25M | $20M | $55M | $22M | $26M | $21M | $22M | $25M | $24M | $24M | $26M | $23M | $21M | $19M | |
| Operating Income | $-18M | $-24M | $-25M | $-20M | $-55M | $-15M | $-19M | $-13M | $-16M | $-20M | $-18M | $-18M | $-20M | $-17M | $-15M | $-15M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $58.0K | · | $58.0K | $58.0K | $58.0K | $56.0K | $58.0K | |
| Interest Income | $1M | $1M | $2M | $2M | $2M | $791.0K | $676.0K | $906.0K | $1M | $1M | $2M | $2M | $2M | $2M | $2M | $620.0K | |
| Other Non-op | $1M | $1M | $2M | $2M | $2M | $88M | $676.0K | $867.0K | $1M | $1M | $1M | $2M | $2M | $2M | $2M | $562.0K | |
| Pretax Income | $-17M | $-22M | · | · | $-53M | $73M | · | · | · | · | $-16M | $-16M | $-18M | · | $-14M | $-14M | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $-9.0K | $0 | |
| Net Income | $-17M | $-22M | $-23M | $-18M | $-53M | $73M | $-18M | $-13M | $-15M | $-18M | $-16M | $-16M | $-18M | $-15M | $-14M | $-14M | |
| EPS (Basic) | $-0.20 | $-0.32 | $-1.15 | $-0.26 | $-0.76 | $1.84 | $-0.68 | $-0.46 | $-0.54 | $-0.68 | $-0.60 | $-0.60 | $-0.67 | $-0.57 | $-0.48 | $-0.68 | |
| EPS (Diluted) | $-0.20 | $-0.32 | $-1.14 | $-0.26 | $-0.76 | $1.83 | $-0.68 | $-0.46 | $-0.54 | $-0.68 | $-0.60 | $-0.60 | $-0.67 | $-0.57 | $-0.48 | $-0.68 | |
| Shares (Basic) | 82,886,196 | 69,236,945 | · | 69,204,899 | 69,083,127 | 39,640,826 | · | 27,041,327 | 27,010,013 | 26,980,698 | · | 26,946,683 | 26,879,089 | 26,862,646 | · | 21,269,163 | |
| Shares (Diluted) | 82,886,196 | 69,236,945 | · | 69,204,899 | 69,083,127 | 39,932,539 | · | 27,041,327 | 27,010,013 | 26,980,698 | · | 26,946,683 | 26,879,089 | 26,862,646 | · | 21,269,163 | |
| EBITDA | $-18M | $-24M | · | $-20M | $-55M | $-15M | · | $-13M | $-16M | $-19M | · | $-18M | $-20M | $-17M | · | $-15M |
资产负债表
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $85M | $35M | $38M | $38M | $145M | $228M | $29M | $31M | $41M | $54M | $63M | $69M | $68M | $34M | $39M | $135M | |
| Short-term Investments | $105M | $88M | $108M | $125M | $32M | $3M | $19M | $32M | $37M | $34M | $46M | $51M | $67M | $117M | $134M | $48M | |
| Receivables | · | · | $0 | $0 | $0 | $0 | $6M | $7M | $6M | $5M | $5M | $6M | $4M | $6M | $2M | $2M | |
| Inventory | · | · | $0 | $0 | $0 | $0 | $5M | $5M | $6M | $6M | $6M | $4M | $3M | $4M | $2M | $734.0K | |
| Prepaid Expense | $2M | $3M | $3M | $2M | $1M | $2M | $3M | $3M | $2M | $3M | $4M | $4M | $3M | $4M | $4M | $4M | |
| Current Assets | $192M | $126M | $149M | $165M | $179M | $233M | $61M | $77M | $93M | $103M | $125M | $133M | $145M | $165M | $180M | $190M | |
| PP&E (Net) | $1.0K | $2.0K | $3.0K | $4.0K | $9.0K | $25.0K | $7M | $6M | $6M | $6M | $5M | $4M | $3M | $2M | $508.0K | $457.0K | |
| PP&E (Gross) | $377.0K | $377.0K | $377.0K | $377.0K | $377.0K | $377.0K | $7M | $6M | $6M | $6M | $5M | $4M | $3M | $2M | $609.0K | · | |
| Accum. Depreciation | $376.0K | $375.0K | $374.0K | $373.0K | $368.0K | $352.0K | $463.0K | $416.0K | $369.0K | $320.0K | $270.0K | $226.0K | $183.0K | $140.0K | $101.0K | · | |
| Intangibles | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | |
| Other Non-current Assets | $2M | $2M | $2M | $2M | $2M | $1M | $1M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Total Assets | $194M | $127M | $151M | $167M | $181M | $234M | $70M | $86M | $102M | $111M | $132M | $140M | $151M | $171M | $184M | $194M | |
| Accounts Payable | $1M | $2M | $917.0K | $2M | $3M | $4M | $2M | $1M | $2M | $3M | $6M | $3M | $3M | $7M | $4M | $4M | |
| Accrued Liabilities | $10M | $9M | $14M | $8M | $5M | $9M | $15M | $14M | $14M | $11M | $14M | $12M | $10M | $11M | $15M | $14M | |
| Current Liabilities | $11M | $11M | $15M | $10M | $9M | $12M | $17M | $16M | $22M | $20M | $26M | $21M | $13M | $18M | $19M | $18M | |
| Capital Leases | · | · | $0 | $0 | $0 | $0 | $565.0K | $624.0K | $682.0K | $738.0K | $833.0K | $946.0K | $1M | $1M | $1M | $1M | |
| Other Non-current Liabilities | · | · | $0 | $0 | $0 | $0 | $202.0K | $393.0K | · | · | $0 | · | · | · | · | · | |
| Total Liabilities | $11M | $11M | $15M | $10M | $9M | $12M | $18M | $17M | $23M | $21M | $27M | $21M | $20M | $25M | $26M | $25M | |
| Common Stock | $5.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | |
| Retained Earnings | $-392M | $-375M | $-353M | $-330M | $-312M | $-260M | $-333M | $-314M | $-302M | $-287M | $-269M | $-253M | $-236M | $-218M | $-203M | $-189M | |
| AOCI | $-63.0K | $-15.0K | $120.0K | $139.0K | $9.0K | $1.0K | $16.0K | $39.0K | $-27.0K | $-8.0K | $27.0K | $-16.0K | $-44.0K | $-32.0K | $-115.0K | $-99.0K | |
| Stockholders' Equity | $183M | $116M | $136M | $157M | $172M | $222M | $52M | $69M | $79M | $90M | $105M | $118M | $131M | $146M | $158M | $169M | |
| Liabilities + Equity | $194M | $127M | $151M | $167M | $181M | $234M | $70M | $86M | $102M | $111M | $132M | $140M | $151M | $171M | $184M | $194M | |
| Shares Outstanding | 57,009,010 | 47,196,564 | 47,145,719 | 47,128,362 | 47,128,362 | 46,784,618 | 24,680,708 | 24,614,834 | 24,614,834 | 24,554,205 | 24,554,205 | 24,525,860 | 24,519,860 | 24,436,990 | 24,435,007 | 24,395,117 |
现金流
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | · | · | · | · | · | · | $50.0K | $44.0K | $44.0K | $43.0K | $38.0K | $46.0K | $12.0K | |
| Stock-based Comp | $2M | $2M | $2M | $3M | $3M | $2M | $2M | $3M | $3M | $4M | $3M | $3M | $3M | $3M | $3M | $3M | |
| Amort. of Intangibles | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $0 | $-32.0K | $0 | |
| Restructuring | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $3M | $0 | $0 | $0 | $0 | · | · | · | · | |
| Other Non-cash | · | · | · | · | · | · | · | · | · | $-5M | · | · | · | $-9M | · | · | |
| Operating Cash Flow | $-15M | $-22M | $-17M | $-15M | $-53M | $-12M | $-15M | $-16M | $-9M | $-20M | $-10M | $-12M | $-17M | $-21M | $-11M | $-8M | |
| CapEx | $0 | $0 | $0 | $0 | $1.0K | $551.0K | $186.0K | $188.0K | $541.0K | $739.0K | $816.0K | $1M | $689.0K | $1M | $78.0K | $102.0K | |
| Investing Cash Flow | $-17M | $19M | $17M | $-92M | $-29M | $115M | $13M | $5M | $-4M | $11M | $4M | $13M | $51M | $16M | $-84M | $-48M | |
| Financing Cash Flow | $82M | $0 | $25.0K | $0 | $-850.0K | $95M | $53.0K | $0 | $87.0K | $-10.0K | $80.0K | $-75.0K | $313.0K | $8.0K | $-107.0K | $73M | |
| Net Change in Cash | $50M | $-3M | $-363.0K | $-107M | $-83M | $199M | $-2M | $-11M | $-13M | $-9M | $-6M | $641.0K | $34M | $-5M | $-96M | $16M | |
| Taxes Paid | · | · | · | · | · | · | · | · | · | · | · | $0 | · | · | · | $0 | |
| Free Cash Flow | · | $-22M | · | · | · | $-12M | · | · | · | $-20M | · | · | · | $-23M | · | · |
盈利能力
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | · | -213.0% | · | -186.0% | -252.2% | -364.5% | · | -299.5% | -315.1% | -286.8% | · | -354.2% | |
| Net Margin | · | · | · | · | · | 1021.9% | · | -174.0% | -236.0% | -341.7% | · | -273.6% | -289.8% | -259.5% | · | -341.0% | |
| Pretax Margin | · | · | · | · | · | · | · | · | · | · | · | -273.6% | -289.8% | · | · | -341.0% | |
| EBITDA Margin | · | · | · | · | · | -213.0% | · | -186.0% | -252.2% | -363.6% | · | -299.5% | -315.1% | -286.1% | · | -354.2% | |
| ROA | -8.9% | -12.3% | · | -14.0% | -37.3% | 42.3% | · | -11.1% | -11.5% | -13.0% | · | -9.8% | -12.8% | -9.7% | · | -8.0% | |
| ROE | -9.4% | -13.1% | · | -15.7% | -41.9% | 46.8% | · | -13.4% | -13.9% | -15.5% | · | -11.3% | -15.0% | -11.2% | · | -9.0% | |
| ROIC | -9.9% | -20.2% | · | · | · | · | · | · | · | · | · | -15.1% | -14.9% | · | · | -8.9% |
流动性与偿付能力
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 17.4 | 11.4 | · | 16.8 | 20.4 | 19.0 | · | 4.9 | 4.2 | 5.2 | · | 6.5 | 11.2 | 9.3 | · | 10.6 | |
| Quick Ratio | 17.2 | 11.1 | · | 16.5 | 20.2 | 18.8 | · | 4.4 | 3.8 | 4.7 | · | 6.1 | 10.7 | 8.8 | · | 10.4 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | -336.4 | · | -307.7 | -337.0 | -290.1 | · | -259.2 |
效率
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.1 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | |
| Inventory Turnover | · | · | · | 0.0 | 0.0 | 0.3 | · | 0.2 | 0.2 | 0.1 | · | 0.3 | 0.3 | 0.3 | · | 1.6 | |
| Receivables Turnover | · | · | · | 0.0 | 0.0 | 2.9 | · | 1.2 | 1.3 | 1.0 | · | 1.5 | 2.2 | 1.4 | · | 3.7 |
每股
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $3.21 | $2.46 | · | $3.33 | $3.65 | $4.74 | · | $2.80 | $3.20 | $3.68 | · | $4.82 | $5.36 | $5.97 | · | $6.93 | |
| Revenue / Share | $0.00 | $0.00 | · | $0.00 | $0.00 | $0.18 | · | $0.27 | $0.23 | $0.20 | · | $0.22 | $0.23 | $0.22 | · | $0.20 | |
| Cash Flow / Share | · | $-0.32 | · | · | · | $-0.30 | · | · | · | $-0.73 | · | · | · | $-0.79 | · | · | |
| Cash / Share | $1.50 | $0.74 | · | $0.80 | $3.08 | $4.86 | · | $1.24 | $1.67 | $2.19 | · | $2.81 | $2.78 | $1.39 | · | $5.53 | |
| EPS (TTM) | $-1.92 | $-2.48 | · | $0.13 | $-0.07 | $0.15 | · | $-2.28 | $-2.42 | $-2.55 | · | $-2.32 | $-2.40 | $-2.60 | · | · |
估值 (TTM)
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | $0 | · | $14M | $22M | $28M | · | $25M | $24M | $24M | · | $23M | $22M | $19M | · | $24M | |
| Net Income TTM | $-80M | $-116M | · | $-16M | $-10M | $28M | · | $-62M | $-65M | $-69M | · | $-63M | $-62M | $-62M | · | · | |
| Market Cap | $261M | $163M | · | $90M | $88M | $83M | · | $51M | $36M | $57M | · | $119M | $168M | $177M | · | $345M | |
| P/E | -2.4 | -1.4 | · | 14.6 | -26.7 | 11.9 | · | -0.9 | -0.6 | -0.9 | · | -2.1 | -2.9 | -2.8 | · | · | |
| P/S | · | · | · | 6.2 | 4.1 | 3.0 | · | 2.0 | 1.5 | 2.4 | · | 5.1 | 7.8 | 9.4 | · | 14.4 | |
| P/B | 1.4 | 1.4 | · | 0.6 | 0.5 | 0.4 | · | 0.7 | 0.5 | 0.6 | · | 1.0 | 1.3 | 1.2 | · | 2.0 | |
| P / Tangible Book | 1.4 | 1.4 | · | 0.6 | 0.5 | 0.4 | · | 0.7 | 0.5 | 0.6 | · | 1.0 | 1.3 | 1.2 | · | 2.0 | |
| P / Cash Flow | · | -7.3 | · | · | · | -7.0 | · | · | · | -2.9 | · | · | · | -8.3 | · | · | |
| Earnings Yield | -41.9% | -71.9% | · | 6.8% | -3.7% | 8.4% | · | -110.7% | -165.8% | -109.0% | · | -47.9% | -35.1% | -35.9% | · | · |
最近期在左侧 · 空值显示为 ·
财务报表 损益表、资产负债表、现金流量表 — 年度，近5年
| 指标 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| 收入 | $7M | $26M | $24M | $15M | $14M |
| 营业利润率 % | -1601.1% | -259.6% | -295.4% | -411.9% | -9930.1% |
| 净收入 | $-21M | $-64M | $-66M | $-61M | $-110M |
| 稀释后每股收益 (EPS) | $-0.33 | $-2.36 | $-2.44 | $-2.69 | $-12.41 |
| 指标 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| 流动比率 | 10.3 | 3.6 | 4.7 | 9.6 | 9.9 |
| 速动比率 | 10.0 | 3.1 | 4.3 | 9.3 | 9.8 |
| 指标 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| 自由现金流 | $-98M | $-61M | $-64M | $-50M | $-22M |
机构持有人 (13F) 82 家申报者 · $202.4M 总计 · 截至 2026年6月30日
在其季度SEC表格13F中报告持有此股票的机构。仅限多头头寸；单个申报人可能因单独的期权腿而出现两次。 大的抵消性看跌/看涨腿通常反映做市或对冲库存，而非方向性判断。
持有人
82
持有价值
$202.4M
新仓位
28
已退出持仓
11
机构活动 — Q2 2026 与上一季度对比
| 新仓位 | 已退出持仓 | 增加 | 减少 | 净股数变动 |
|---|---|---|---|---|
| 28 (+6 与上一季度对比) | 11 (+7 与上一季度对比) | 30 (+15 与上一季度对比) | 10 (+2 与上一季度对比) | +9.0M |
与Q1 2026对比。 SEC 13F表格的提交截止日期是季度末后45天，外加少量延迟提交的缓冲期——在此窗口期内的季度将被跳过，优先显示最近一个已完整报告的季度对。
| 机构 | 价值 | 股份 | % 已追踪的13F | 类型 |
|---|---|---|---|---|
| Yu Fan | $22264818 | 4861314 | 11.00% | 股份 |
| ACUTA CAPITAL PARTNERS, LLC | $21461477 | 4685912 | 10.60% | 股份 |
| QVT Financial LP | $21139947 | 4615709 | 10.44% | 股份 |
| MONTANOVA CAPITAL, LLC | $19694000 | 4300000 | 9.73% | 股份 |
| ORBIMED ADVISORS LLC | $18019076 | 3934296 | 8.90% | 股份 |
| Avoro Capital Advisors LLC | $13050261 | 2849402 | 6.45% | 股份 |
| Siren, L.L.C. | $10703927 | 2337102 | 5.29% | 股份 |
| KVP Capital Advisors, LP | $9920266 | 2165997 | 4.90% | 股份 |
| BlackRock, Inc. | $8806552 | 1922828 | 4.35% | 股份 |
| VANGUARD CAPITAL MANAGEMENT LLC | $6359609 | 1388561 | 3.14% | 股份 |
| ADAR1 Capital Management, LLC | $6143585 | 1341394 | 3.04% | 股份 |
| ACORN CAPITAL ADVISORS, LLC | $5218283 | 1139363 | 2.58% | 股份 |
| STEMPOINT CAPITAL LP | $4676349 | 1021037 | 2.31% | 股份 |
| GEODE CAPITAL MANAGEMENT, LLC | $4121928 | 899780 | 2.04% | 股份 |
| VANGUARD GROUP INC | $3848082 | 1590117 | 1.90% | 股份 |
| Ally Bridge Group (NY) LLC | $3746161 | 817939 | 1.85% | 股份 |
| Woodline Partners LP | $1999692 | 436614 | 0.99% | 股份 |
| RENAISSANCE TECHNOLOGIES LLC | $1895305 | 413822 | 0.94% | 股份 |
| STATE STREET CORP | $1772378 | 386982 | 0.88% | 股份 |
| MILLENNIUM MANAGEMENT LLC | $1742259 | 380406 | 0.86% | 股份 |
| Eversept Partners, LP | $1389141 | 303306 | 0.69% | 股份 |
| Verdad Advisers, LP | $1380792 | 301483 | 0.68% | 股份 |
| TWO SIGMA INVESTMENTS, LP | $1358483 | 296612 | 0.67% | 股份 |
| AMES NATIONAL CORP | $1333269 | 4571 | 0.66% | 股份 |
| Balyasny Asset Management L.P. | $1319576 | 288117 | 0.65% | 股份 |
| NORTHERN TRUST CORP | $1212276 | 264689 | 0.60% | 股份 |
| VANGUARD FIDUCIARY TRUST CO | $1130834 | 246907 | 0.56% | 股份 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $1004014 | 219217 | 0.50% | 股份 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $757001 | 165284 | 0.37% | 股份 |
| GOLDMAN SACHS GROUP INC | $580552 | 126758 | 0.29% | 股份 |
| Bank of New York Mellon Corp | $378455 | 82632 | 0.19% | 股份 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $361051 | 78832 | 0.18% | 股份 |
| Point72 Asset Management, L.P. | $261651 | 57129 | 0.13% | 股份 |
| AMERICAN CENTURY COMPANIES INC | $237427 | 51840 | 0.12% | 股份 |
| UBS Group AG | $232851 | 50841 | 0.12% | 股份 |
| Qube Research & Technologies Ltd | $224388 | 48993 | 0.11% | 股份 |
| Nuveen, LLC | $200599 | 43799 | 0.10% | 股份 |
| Jump Financial, LLC | $186864 | 40800 | 0.09% | 股份 |
| Invesco Ltd. | $179440 | 39179 | 0.09% | 股份 |
| BANK OF AMERICA CORP /DE/ | $158587 | 34626 | 0.08% | 股份 |
| DIMENSIONAL FUND ADVISORS LP | $153064 | 33420 | 0.08% | 股份 |
| DEUTSCHE BANK AG\ | $145039 | 31668 | 0.07% | 股份 |
| CITADEL ADVISORS LLC | $137794 | 30086 | 0.07% | 股份 |
| MORGAN STANLEY | $137309 | 29980 | 0.07% | 股份 |
| WELLS FARGO & COMPANY/MN | $124457 | 27174 | 0.06% | 股份 |
| RHUMBLINE ADVISERS | $112338 | 24529 | 0.06% | 股份 |
| Y-Intercept (Hong Kong) Ltd | $111583 | 24363 | 0.06% | 股份 |
| TWO SIGMA ADVISERS, LP | $102608 | 42400 | 0.05% | 股份 |
| Vanguard Global Advisers, LLC | $89205 | 19477 | 0.04% | 股份 |
| NEW YORK STATE COMMON RETIREMENT FUND | $85646 | 18700 | 0.04% | 股份 |
激进投资者及 5%+ 股东 13 持仓
提交了 SEC Schedule 13D 的投资者 — 持有超过 5% 的受益所有权，意图影响发行人（激进股东持股、董事会活动、并购）。每一行显示该申报人持仓的最新已知状态。
| 申报人 | 已申报 | 持股 | 状态 | 目的 | 申报 |
|---|---|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC, ANUPAM DALAL, Acuta Capital Fund, LP ×3 申报 | 2026年5月18日 | 9.00% | 修订 | 被动投资 | SEC |
| Avoro Capital Advisors LLC, Avoro Ventures LLC, Behzad Aghazadeh ×6 申报 | 2026年5月14日 | 19.99% | 修订 | · | SEC |
| Neil Desai ×5 申报 | 2025年3月6日 | 4.90% | 修订 | · | SEC |
| BML Investment Partners, L.P., Leonard Braden Michael ×5 申报 | 2025年3月5日 | 4.98% | 修订 | 被动投资 | SEC |
| Muneer A. Satter (2) ×5 申报 | 2021年11月12日 | · | 初始申报 | · | SEC |
| OrbiMed Advisors LLC, OrbiMed Capital GP V LLC ×4 申报 | 2021年9月3日 | · | 初始申报 | · | SEC |
| Novartis Bioventures Ltd., Novartis AG ×7 申报 | 2020年5月15日 | · | 初始申报 | · | SEC |
| Kearny Venture Partners, L.P. (“KVP”), Kearny Venture Partners Entrepreneurs’ Fund, L.P. (“KVPE”), Kearny Venture Associates, L.L.C. (“KVA”), Caley Castelein (“Castelein”), Richard Spalding (“Spalding”), James Shapiro (“Shapiro”) ×2 申报 | 2018年10月4日 | · | 初始申报 | · | SEC |
| Novartis Bioventures Ltd. (2), Novartis AG (2) | 2017年3月27日 | · | 初始申报 | · | SEC |
| Venture Investors Early Stage Fund IV Limited Partnership (2), VIESF IV GP LLC (2) | 2017年3月27日 | · | 初始申报 | · | SEC |
| 未披露的报告人 | 2008年4月4日 | · | 初始申报 | · | SEC |
| 未披露的报告人 | 2008年4月4日 | · | 初始申报 | · | SEC |
| Argyris Vassiliou | 2008年4月4日 | · | 初始申报 | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
公司内部人士 28 位内幕人士 · 12 位高管 · 17 位董事
| 内部人士 | 角色 | 上次活动 | 持股数量 | 买入 12个月 | 卖出 12个月 | 净额 12个月 |
|---|---|---|---|---|---|---|
| David James Lennon | CHIEF EXECUTIVE OFFICER | 2026年9月15日 A | 569643 | 0 | 6 | $-1058894 |
| Brendan Delaney | President and Chief Executive Officer | 2023年3月1日 A | 20000 | 0 | 0 | $0 |
| Stephen J Hoffman | Chief Executive Officer | 2019年5月14日 A | 31967 | 0 | 0 | $0 |
| Scott M. Giacobello | CHIEF FINANCIAL OFFICER | 2026年9月15日 A | 333489 | 0 | 3 | $-890614 |
| Joseph H. Gardner | President | 2020年3月16日 A | 453019 | 0 | 0 | $0 |
| Margaret Dugan | Chief Medical Officer | 2026年9月15日 A | 19132 | 0 | 0 | $0 |
| David Dornan | Chief Scientific Officer | 2026年9月15日 A | · | 0 | 0 | $0 |
| Bryan Ball | Chief Technical Operations Officer | 2026年9月15日 A | 448126 | 0 | 5 | $-635055 |
| Lorettta M Itri | CHIEF MEDICAL OFFICER | 2024年3月1日 A | · | 0 | 0 | $0 |
| Kevin G. Peters | Chief Scientific Officer and Acting Chief Medical Officer Exhibit 24: Power of Attorney | 2020年3月16日 A | 320536 | 0 | 0 | $0 |
| Michael W Rogers | Chief Financial and Chief Business Officer | 2019年5月14日 A | · | 0 | 0 | $0 |
| Steve Pakola | Chief Medical Officer | 2019年2月15日 A | · | 0 | 0 | $0 |
| Vijay K Iyengar | 董事 | 2026年9月9日 A | · | 0 | 0 | $0 |
| Baiteng Zhao | 董事 | 2026年6月12日 A | 1250000 | 0 | 0 | $0 |
| Neil Desai | 董事 | 2026年6月12日 A | 1211543 | 0 | 0 | $0 |
| Emma Reeve | 董事 | 2026年6月12日 A | · | 0 | 0 | $0 |
| Mohammad Hirmand | 董事 | 2026年6月12日 A | · | 0 | 0 | $0 |
| Anupam Dalal | 董事 | 2026年6月12日 A | 4685912 | 0 | 0 | $0 |
| Richard E Maroun | 董事 | 2026年6月12日 A | · | 0 | 0 | $0 |
| Caley Castelein | 董事 | 2026年6月12日 A | 274796 | 0 | 0 | $0 |
| Karin M. Hehenberger | 董事 | 2024年6月12日 A | · | 0 | 0 | $0 |
| Cheryl Cohen | 董事 | 2021年6月17日 A | 8020 | 0 | 0 | $0 |
| Chau Quang Khuong | 董事 | 2019年6月18日 A | 5193946 | 0 | 0 | $0 |
| Satter Muneer A | 董事 | 2019年6月18日 A | 5621835 | 0 | 0 | $0 |
| Paul M Weiss | 董事 | 2017年3月15日 P | 1576167 | 0 | 0 | $0 |
| Dugel Pravin | · | 2021年6月30日 A | 12568 | 0 | 0 | $0 |
| Steven Prelack | · | 2021年6月30日 A | 24485 | 0 | 0 | $0 |
| Regina Marek | · | 2020年3月16日 A | · | 0 | 0 | $0 |
来自SEC表格3/4/5申报的内部人士；净额=仅公开市场买卖
ETF持仓 由 10 只交易所交易基金持有
权重仅反映直接股权持仓（N-PORT）；杠杆基金或基于衍生品的基金可能持有未显示的额外掉期敞口。
| 基金 | 权重 | 单位 | 截至 | 来源 |
|---|---|---|---|---|
| QQQS · Invesco Exchange-Traded Fund Trus... | 0.43% | 26402 SH | 2026年10月1日 | 每日 |
| IWC · iShares Trust | 0.03% | 109848 SH | 2026年9月11日 | 每日 |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0.01% | 28211 SH | 2026年8月19日 | 每日 |
| RSSL · Global X Funds | 0.00% | 15506 NS | 2026年7月31日 | N-PORT |
| IWM · iShares Trust | 0.00% | 720704 SH | 2026年9月11日 | 每日 |
| VXF · VANGUARD INDEX FUNDS | 0.00% | 470854 SH | 2026年8月19日 | 每日 |
| VTI · VANGUARD INDEX FUNDS | 0.00% | 887972 SH | 2026年8月19日 | 每日 |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0.00% | 187597 SH | 2026年8月19日 | 每日 |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.00% | 3409 SH | 2026年8月19日 | 每日 |
| IWN · iShares Trust | · | 311545 SH | 2026年9月11日 | 每日 |
WHWK 分析师共识 看涨和看跌分析师观点、12个月价格目标、上涨空间
评级 · 14 位分析师
买入
中位数目标
$8.00
+116.2%
4 28.6%
强烈买入
6 42.9%
买入
4 28.6%
持有
0 0.0%
卖出
0 0.0%
强烈卖出
12个月价格目标
7 位分析师 · 2026-10-03平均目标 $7.71 +108.5%
← 低于所有目标
当前价格 $3.70
最低$4.00
平均值$7.71
最高$10.00
同行比较（GICS 子行业） 关键指标与行业同行对比
财年依据，价格截至各公司上一个财年末收盘价。
| 股票代码 | 市值 | P/E | 营收同比增长 | 净利润率 | ROE | 毛利率 |
|---|---|---|---|---|---|---|
| WHWK | $114M | -7.3 | -72.5% | -288.3% | -13.4% | · |
| RNAC | $188M | -1.4 | -92.8% | -4658.6% | 202.4% | · |
| SION | $1.84B | -21.9 | · | · | -23.4% | · |
| TRDA | $394M | -3.0 | -87.9% | -565.5% | -41.9% | · |
| ELDN | $114M | -2.9 | · | · | -69.4% | · |
| ALEC | $172M | -1.1 | -79.1% | -679.2% | -280.7% | · |
| CUE | $29M | -1.1 | 195.8% | -96.9% | -119.3% | · |
| NKTX | $131M | -1.3 | · | · | -31.1% | · |
| CNTN | $112M | -2.7 | · | · | -18.0% | · |
| CHRS | $172M | 1.0 | 59.8% | 398.4% | 185.8% | · |
我的指标 您的个人关注列表 — 来自完整基本面的选定行
选择对您重要的指标 — 点击上方完整基本面中任意行的 + 号。
您的选择已保存，并会跟随您浏览所有股票。
来源：SEC 10-Q 于 八月 6, 2026 申报